As the delta variant ravages communities throughout the Unites States, it is important to look past the data and remember that every infection, hospitalization and death leaves an indelible mark on that patient’s family and community. And few communities have suffered as much as Black communities in the ... READ MORE >
FDA
5 things to know in life sciences: Week of September 13
This week we explore promising developments in CRISPR genome editing, also known as clustered regularly interspaced short palindromic repeats, a bacterial defense system. We also look at two of the latest U.S. Food and Drug Administration’s approvals, including another one for a surgical robot that ... READ MORE >
5 things to know in life sciences: Week of August 2
This week we start with a look at the potential for gene and cell therapy to radically change health care over the coming decade. Although there are few approved drugs using these technologies today, the pipeline of candidates in all phases of clinical studies is full of potential cell and gene therapy ... READ MORE >
5 things to know in life sciences: Week of July 12
The medical devices sector is booming with activity as evidenced by the 114% year-over-year increase in industry-funded medical devices trial starts for the period of January through May. This week, we explore new technologies contributing to the medical devices boom, including a miniature surgical robot ... READ MORE >
5 things to know in life sciences: Week of June 14
Given the high volume of mergers and acquisitions in life sciences, changes in the leadership and focus of the Federal Trade Commission will be closely watched in the coming months as scrutiny could shift to the technology industry. We examine the possible impact below. We also look at CureVac’s ... READ MORE >
5 things to know in life sciences: Week of June 7
The U.S. Food and Drug Administration’s approval of the Alzheimer’s drug, aducanumab, ushered in both a likely blockbuster for developer Biogen and sparked a debate both within the biopharma industry and among health care providers. We also look at a major medical device acquisition, investment in ... READ MORE >
5 things to know in life sciences: Week of May 31
Recruiting and retaining patients for clinical trials is one of the most intractable problems facing clinical research organizations and biopharma companies. CVS thinks that its thousands of retail locations could be the answer. We also look at Food and Drug Administration-approved video games, tracking ... READ MORE >
5 things to know in life sciences: Week of May 3
Public health experts are raising new concerns that achieving herd immunity in the United States looks increasingly unlikely. Although this doesn’t reduce the urgent need to get as many people vaccinated as possible, it does mean that we may need to begin planning for how we will live with COVID-19 as an ... READ MORE >
5 things to know in life sciences: Week of April 26
Getting people vaccinated can be a public health challenge. Getting them to come back for a second dose at the right time can be even more difficult. This week we highlight why people may be skipping their second COVID-19 dose and how challenging getting that second dose can be even for people motivated ... READ MORE >
5 things to know in life sciences: Week of April 19
This week we look at comments from acting Food and Drug Administration commissioner Janet Woodcock on perceptions that the agency is getting tougher on drug companies during the approval process. We also highlight new uses of CRISPR to control gene expression, venture funds focused on life sciences, newly ... READ MORE >